Literature DB >> 19135119

Metabolism of cisplatin to a nephrotoxin.

Marie H Hanigan, Danyelle M Townsend, Arthur J L Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19135119      PMCID： PMC2708784          DOI： 10.1016/j.tox.2008.12.014

Source DB:  PubMed          Journal:  Toxicology        ISSN： 0300-483X            Impact factor:   4.221


× No keyword cloud information.
  13 in total

1.  Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin.

Authors:  Lei Zhang; Marie H Hanigan
Journal:  J Pharmacol Exp Ther       Date:  2003-05-15       Impact factor: 4.030

2.  Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.

Authors:  Danyelle M Townsend; Marie H Hanigan
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

3.  Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.

Authors:  Claudio Jösch; Lars-Oliver Klotz; Helmut Sies
Journal:  Biol Chem       Date:  2003-02       Impact factor: 3.915

4.  Purification of soluble and mitochondrial glutamine transaminase K from rat kidney. Use of a sensitive assay involving transamination between L-phenylalanine and alpha-keto-gamma-methiolbutyrate.

Authors:  A J Cooper
Journal:  Anal Biochem       Date:  1978-09       Impact factor: 3.365

5.  Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.

Authors:  M H Hanigan; B C Gallagher; P T Taylor
Journal:  Am J Obstet Gynecol       Date:  1996-08       Impact factor: 8.661

6.  Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin.

Authors:  M H Hanigan; E D Lykissa; D M Townsend; C N Ou; R Barrios; M W Lieberman
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

7.  Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells.

Authors:  Trevor A McGoldrick; Edward A Lock; Vicente Rodilla; Gabrielle M Hawksworth
Journal:  Arch Toxicol       Date:  2003-04-17       Impact factor: 5.153

8.  High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of Cisplatin.

Authors:  Danyelle M Townsend; Jarrod A Marto; Mei Deng; Timothy J Macdonald; Marie H Hanigan
Journal:  Drug Metab Dispos       Date:  2003-06       Impact factor: 3.922

9.  Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.

Authors:  M H Hanigan; B C Gallagher; P T Taylor; M K Large
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701

10.  Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

Authors:  Danyelle M Townsend; Mei Deng; Lei Zhang; Maia G Lapus; Marie H Hanigan
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121
View more
  1 in total

1.  The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles.

Authors:  Badreldin H Ali; Mohammed Al Za'abi; Asem Shalaby; Priyadarsini Manoj; Mostafa I Waly; Javed Yasin; Mohamed Fahim; Abderrahim Nemmar
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.